CB, I wouldn’t bother wasting your time explaining this. The...

First 25 Last

Share
Profile

Follow
SynQuasi

1,094 Posts.

33

13/06/18

10:14

Post #: 33672268
Share

Originally posted by crystalblue ↑

Hi Gillys,

What aspects of this report did you find inconclusive?

Do you dispute there is not enough evidence to support that Nearmap will breakeven & turn a small profit ($1.01m or otherwise) in 2019?

Or do you dispute the stated average 113.98% year-on-year growth is not sustainable or realistic?

Another item that comes to my mind is of course their continuous expenditures, I guess although Nearmap has announced that they are now in the sales cycle and winding down their intensive investments, the size of this “winded down” expenditure and how this relates & grows with sales into the future is yet to be seen.

I understand Nearmap has seen a few false starts in the past and some investors have jumped on with very short term expectations & hopes that things will take off into the sky but then dashed with the company’s higher expenditures.

But the truth is, we all know Nearmap is making a profit and we all know these profits are being sacrificed into the US (hence the company losses in the past few years), but as their sales growth is higher than their expenditure growth surely you too can see a point of breakeven will be reached soon. And as time passes, we are only getting closer (& not further) to this breakeven point than ever before.

Expand

CB, I wouldn’t bother wasting your time explaining this. The same happened when the Aussie operations first reported profitability the SP shot up even though the same logic you mention prior to the official announcement.

All the best for us who can see it coming!

NEA Price at posting: $1.07 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ASX Market Close: ASX closes above 8,400pts on green Wednesday | Nov 27, 2024

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 20 more messages in this thread...

First 25 Last

Add NEA (ASX) to my watchlist

CB, I wouldn’t bother wasting your time explaining this. The...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ASX Market Close: ASX closes above 8,400pts on green Wednesday | Nov 27, 2024

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up